These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 825431)

  • 21. Final report on carcinogens background document for riddelliine.
    National Toxicology Program
    Rep Carcinog Backgr Doc; 2008 Aug; (8-5977):i-104. PubMed ID: 20737008
    [No Abstract]   [Full Text] [Related]  

  • 22. More light on pyrrolizidine alkaloids.
    Cooper P
    Food Cosmet Toxicol; 1979 Oct; 17(5):547-9. PubMed ID: 520986
    [No Abstract]   [Full Text] [Related]  

  • 23. DNA adducts of pyrrolizidine alkaloids, nitroimidazoles and aristolochic acid.
    Wiessler M
    IARC Sci Publ; 1994; (125):165-77. PubMed ID: 7806311
    [No Abstract]   [Full Text] [Related]  

  • 24. THE EFFECT OF CYANIDE AND AZIDE ON THE MUTAGENIC ACTIVITY OF THE PYRROLIZIDINE ALKALOID HELIOTRINE IN DROSOPHILA MELANOGASTER.
    BRINK NG
    Z Vererbungsl; 1963 Dec; 94():331-5. PubMed ID: 14123301
    [No Abstract]   [Full Text] [Related]  

  • 25. Carcinogenicity of plant constituents: pyrrolizidine alkaloids, flavonoids, bracken fern.
    Hirono I
    Prog Clin Biol Res; 1986; 206():45-53. PubMed ID: 3952097
    [No Abstract]   [Full Text] [Related]  

  • 26. Toxicology and carcinogenesis studies of riddelliine (CAS No. 23246-96-0) in F344/N rats and B6C3F1 mice (gavage studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2003 May; (508):1-280. PubMed ID: 12844193
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An investigation into the carcinogenicity of monocrotaline pyrrole.
    Hooson J; Grasso P; Mattocks AR
    J Pathol; 1973 Jul; 110(3):P8-9. PubMed ID: 4744071
    [No Abstract]   [Full Text] [Related]  

  • 28. MicroRNA expression profiles distinguish the carcinogenic effects of riddelliine in rat liver.
    Chen T; Li Z; Yan J; Yang X; Salminen W
    Mutagenesis; 2012 Jan; 27(1):59-66. PubMed ID: 21976715
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Malignant tumors in rats given lasiocarpine.
    Svoboda DJ; Reddy JK
    Cancer Res; 1972 May; 32(5):908-13. PubMed ID: 4336029
    [No Abstract]   [Full Text] [Related]  

  • 30. Comparative effects of the pyrrolizidine alkaloids jacobine and monocrotaline on hepatic drug metabolising enzymes in the rat.
    Miranda CL; Cheeke PR; Buhler DR
    Res Commun Chem Pathol Pharmacol; 1980 Sep; 29(3):573-87. PubMed ID: 6775360
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Carcinogenic and mutagenic activity of an alkaloidal extract of Senecio nemorensis ssp. fuchsii.
    Habs H; Habs M; Marquardt H; Röder E; Schmähl D; Wiedenfeld H
    Arzneimittelforschung; 1982; 32(2):144-8. PubMed ID: 7199918
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Spasmolytic properties of pyrrolizidine alkaloids].
    Litvinchuk MD; Gaĭduk RI; Kit VI
    Farmakol Toksikol; 1979; 42(5):509-11. PubMed ID: 488324
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Initiation and selection of resistant hepatocyte nodules in rats given the pyrrolizidine alkaloids lasiocarpine and senecionine.
    Hayes MA; Roberts E; Farber E
    Cancer Res; 1985 Aug; 45(8):3726-34. PubMed ID: 2861891
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Health hazards of pyrrolizidine alkaloids: a short review.
    Schoental R
    Toxicol Lett; 1982 Mar; 10(4):323-6. PubMed ID: 7046139
    [No Abstract]   [Full Text] [Related]  

  • 35. IARC monographs on the evaluation of the carcinogenic risk of chemicals to man: some naturally occurring substances.
    IARC Monogr Eval Carcinog Risk Chem Man; 1976; 10():1-342. PubMed ID: 992652
    [No Abstract]   [Full Text] [Related]  

  • 36. Estimated intakes of pyrrolizidine alkaloids by humans. A comparison with dose rates causing tumors in rats.
    Culvenor CC
    J Toxicol Environ Health; 1983; 11(4-6):625-35. PubMed ID: 6620404
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comfrey toxicity revisited.
    Rode D
    Trends Pharmacol Sci; 2002 Nov; 23(11):497-9. PubMed ID: 12413798
    [No Abstract]   [Full Text] [Related]  

  • 38. Factors affecting the chronic hepatotoxicity of pyrrolizidine alkaloids.
    Jago MV
    J Pathol; 1971 Sep; 105(1):1-11. PubMed ID: 5129752
    [No Abstract]   [Full Text] [Related]  

  • 39. Attenuation of the toxicity of a pyrrolizidine alkaloid (monocrotaline) by metabolic inhibition.
    Eisenstein D; Azari J; Huxtable R
    Proc West Pharmacol Soc; 1979; 22():193-8. PubMed ID: 160042
    [No Abstract]   [Full Text] [Related]  

  • 40. Aziridine.
    IARC Monogr Eval Carcinog Risk Chem Man; 1975; 9():37-46. PubMed ID: 186395
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.